-
1
-
2
A straightforward microfluidic-based approach toward optimizing transduction efficiency of HIV-1-derived lentiviral vectors in BCP-ALL cells
Published 2023-06-01Subjects: Get full text
Article -
3
Artificial Intelligence‐Based Approaches for AAV Vector Engineering
Published 2025-03-01Subjects: Get full text
Article -
4
Long-term stability of clinical-grade lentiviral vectors for cell therapy
Published 2024-03-01Subjects: Get full text
Article -
5
Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins
Published 2024-09-01Subjects: Get full text
Article -
6
Transduction Efficiency and Immunogenicity of Viral Vectors for Cochlear Gene Therapy: A Systematic Review of Preclinical Animal Studies
Published 2021-08-01Subjects: “…transduction efficiency…”
Get full text
Article -
7
Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate
Published 2023-09-01Subjects: Get full text
Article -
8
Semi-automated workflows to quantify AAV transduction in various brain areas and predict gene editing outcome for neurological disorders
Published 2023-06-01Subjects: Get full text
Article -
9
-
10
Site-Directed Mutagenesis Improves the Transduction Efficiency of Capsid Library-Derived Recombinant AAV Vectors
Published 2020-06-01Subjects: Get full text
Article -
11
Glycol chitosan stabilized bimolecular nanoparticles for chemo photothermal killing of breast cancer cells
Published 2022-06-01Subjects: Get full text
Article -
12
-
13
Computer-Aided Directed Evolution Generates Novel AAV Variants with High Transduction Efficiency
Published 2023-03-01Subjects: Get full text
Article -
14
Glycosylation of recombinant adeno-associated virus serotype 6
Published 2024-06-01Subjects: Get full text
Article -
15
Generation of Helper Plasmids Encoding Mutant Adeno-associated Virus Type 2 Capsid Proteins with Increased Resistance against Proteasomal Degradation
Published 2013-07-01Subjects: “…Gene therapy Viral vector Adeno-associated virus type 2 Capsid protein Proteasomal degradation Mutagenesis Transduction efficiency…”
Get full text
Article -
16
Drug product attributes predict clinical efficacy in betibeglogene autotemcel gene therapy for β-thalassemia
Published 2023-12-01Subjects: Get full text
Article -
17
<i>In vivo</i> evaluation of tropism and biodistribution of synthetic and natural adeno-associated viral vectors by next-generation sequencing
Published 2024-07-01Subjects: Get full text
Article